A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe.

NCT07301866 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Acute Leukemia, High Risk
Myelodysplastic Syndromes, High Risk
Hematologic Malignancy Requiring an Allogeneic Hematopoietic Stem Cell Transplant Lacking a Donor

Interventions

BIOLOGICAL: ECT-001-CB

Sponsor

Ciusss de L'Est de l'Île de Montréal

Collaborators

[object Object]